| Literature DB >> 30867540 |
Lucieny da Silva Pontes1,2, Bianca Callegari2, Lizandra Magno1, Anderson Moraes1, Bruno Giovanni Silva1, Kaio Manso2, Brenison Barros1, Ana Paula Araújo1, Maria Clara Silva1, George Alberto Dias1, Beatriz Helena Vasconcelos2, Anselmo Costa E Silva2, Rosana Maria Libonati2, Givago Silva Souza3.
Abstract
Balance disorders have been poorly investigated and somewhat neglected in people infected with the human immunodeficiency virus, especially in children, whose have intrinsic and extrinsic risk factors that may compromise the balance. To evaluate the foot plantar pressures and the balance in children with acquired immunodeficiency. We recruited 53 children aged between 6 and 15 years: 33 healthy children, and 20 children with positive serology for the human immunodeficiency virus. A physical examination included anthropometric, reflexes, tactile sensitivity of the foot and orthopedic evaluation. We also collected data of them using Pediatric Equilibrium Scale, baropodometry, and stabilometry. We considered significance level of 0.05 for statistics. Both groups were aged-, sex-matched and similar body mass index and scores of the Pediatric Equilibrium Scale. Three infected children had altered tactile sensitivity, and none had orthopedic or reflex alteration. Infected children had higher mean plantar pressure in the hindfoot than of the control group (p = 0.02). There was higher maximum plantar pressure in the hindfoot of the infected children than of the controls (p = 0.04). Controls had lower maximum plantar pressure in the forefoot than the infected children (p = 0.04). Infected children had larger displacement of the center of pressure (p = 0.006), larger mean velocity of displacement (p = 0.006), and longer duration between successive peaks of displacement than the controls (p = 0.02). Children living with the human immunodeficiency virus discharges great plantar pressures in the hindfoot and to present balance disturbances in the absence of neurological symptomatology.Entities:
Mesh:
Substances:
Year: 2019 PMID: 30867540 PMCID: PMC6416285 DOI: 10.1038/s41598-019-41028-0
Source DB: PubMed Journal: Sci Rep ISSN: 2045-2322 Impact factor: 4.379
Comparison of the general features of control group and HIV infected group (HIV+).
| Variables | Groups |
| |
|---|---|---|---|
| Control | HIV+ | ||
|
| 12 F/21 M | 8 F/12 M | 0.97 |
|
| 9.5 ± 2.4 | 9.6 ± 2.6 | 0.99 |
|
| 36.55 ± 15.77 | 29.16 ± 8.9 | 0.12 |
|
| 131.7 ± 33.8 | 130.7 ± 13.8 | 0.15 |
|
| 18.2 ± 4.2 | 16.6 ± 2.3 | 0.31 |
|
| 55.3 ± 0.9 | 55.1 ± 1.2 | 0.51 |
F: female; M: male; BMI: body mass index; PBS: pediatric balance scale.
Laboratorial characterization of the HIV+.
| Subjects | Viral load (copies/mm) | CD4 (cells/mm) | CD8 (cells/mm) | ART duration (years) | Drug therapy |
|---|---|---|---|---|---|
|
| 1.558 | 579 | 1.300 | 9 | ddl/3TC/LPV/r |
|
| <40 | 752 | 796 | 6 | EFZ/3TC/AZT |
|
| 559.651 | 21 | 1.307 | 9 | LPV/r/AZT/3TC |
|
| 283.52 | 388 | 3.041 | 11 | EFZ/AZT/3TC |
|
| 1.315 | 486 | 603 | 10 | EFZ/AZT/3TC |
|
| 4.326 | 816 | 2.785 | 4 | NVP/3TC/AZT |
|
| ND | 202 | 1.598 | 6 | EFZ/AZT/3TC |
|
| 147 | 564 | 1.479 | 5 | EFZ/AZT/3TC |
|
| 36.435 | 1.364 | 899 | 6 | LPV/3TC/AZT |
|
| <40 | 564 | 1.479 | 5 | LPV/3TC/AZT |
|
| ND | 1.364 | 899 | 6 | EFZ/AZT/3TC |
|
| 124 | 628 | 674 | 9 | LPV/3TC/AZT |
|
| 63.328 | 431 | 699 | 5 | EFZ/3TC/AZT |
|
| ND | 1.281 | 1.117 | 7 | EFZ/AZT/3TC |
|
| ND | 712 | 507 | 7 | EFZ/AZT/3TC |
|
| NI | NI | NI | 2 | AZT/3TC/NVP |
|
| NI | NI | NI | 5 | AZT/3TC/NVP |
|
| 521.149 | 146 | 1.115 | 10 | EFZ/AZT/LPV |
|
| 75 | 965 | 936 | 8 | AZT/3TC/KALETRA |
|
| 2.346 | 1.519 | 1.866 | 2 | AZT/3TC/NVP |
ART: antiretroviral therapy; ND: non-detectable; NI: non-informed; ddl: Didanosine; 3TC: Lamivudina; LPV/r: Lopinavir + ritonavir; EFZ: Efavirez; AZT: Zidovudina; NVP: Neviparina.
Comparison of the mean plantar pressure, in kPa, (10−3 × mean ± standard deviation) between control group and HIV+.
| Region | Open-eyed condition | Closed eye condition | ||||
|---|---|---|---|---|---|---|
| Control | HIV+ |
| Control | HIV+ |
| |
|
| 32.8 ± 26 | 23.8 ± 36.5 | 0.3 | 38 ± 30.8 | 50.5 ± 48.7 | 0.67 |
|
| 12.6 ± 14.7 | 7.4 ± 16.7 | 0.25 | 12 ± 15.8 | 4.9 ± 9.6 | 0.1 |
|
| 94.4 ± 21.7 | 98.3 ± 17.3 | 0.51 | 98.7 ± 19.5 | 100.1 ± 19.4 | 0.8 |
|
| 112.5 ± 20.1 | 106.4 ± 21.8 | 0.3 | 111.7 ± 20.6 | 107.7 ± 22.1 | 0.62 |
|
| 115 ± 23.4 | 108.4 ± 23.7 | 0.33 | 113.8 ± 22.7 | 112.5 ± 21.5 | 0.83 |
|
| 113.6 ± 24.5 | 105.3 ± 18.3 | 0.2 | 112.8 ± 25.1 | 103.9 ± 20.6 | 0.19 |
|
| 89.9 ± 18.2 | 87 ± 13 | 0.54 | 87.4 ± 18.7 | 87.9 ± 14.3 | 0.91 |
|
| 69.9 ± 26.1 | 64.3 ± 34.8 | 0.51 | 69.8 ± 27.7 | 64.9 ± 36.2 | 0.58 |
|
| 188.3 ± 34.2 | 209 ± 40.9 | 0.05 | 188.5 ± 37.8 | 207.4 ± 35.5 | 0.08 |
|
| 171 ± 30.9 | 190.1 ± 38.5 | 0.05 |
| ||
The comparisons with significant differences are in bold.
Comparison of the maximum plantar pressure, in kPa, (10−3 × mean ± standard deviation) between control group and HIV+.
| Region | Open-eyed condition | Closed eye condition | ||||
|---|---|---|---|---|---|---|
| Control | HIV+ |
| Control | HIV+ |
| |
|
| 33.6 ± 31.4 | 21.1 ± 41 | 0.22 |
| ||
|
| 12.5 ± 16 | 7.7 ± 18.6 | 0.33 |
| ||
|
| 95.7 ± 24.8 | 92.4 ± 27 | 0.65 | 96.5 ± 23.4 | 94.3 ± 27.9 | 0.76 |
|
| 96.2 ± 18.7 | 88.1 ± 24.8 | 0.18 | 93 ± 19.1 | 90.2 ± 21.1 | 0.62 |
|
| 93.5 ± 21.1 | 86.1 ± 22.1 | 0.22 | 92.1 ± 21.5 | 90.7 ± 20.7 | 0.82 |
|
| 92.8 ± 21.3 | 85.5 ± 18.9 | 0.21 | 90.9 ± 23.1 | 86 ± 22 | 0.44 |
|
| 86.8 ± 22.7 | 76.5 ± 12.9 | 0.11 | 86.5 ± 21.9 | 78.1 ± 13 | 0.1 |
|
| 73.3 ± 29.4 | 63.2 ± 35.7 | 0.27 | 70.2 ± 33.1 | 62.4 ± 37.9 | 0.43 |
|
| 214.1 ± 50.1 | 241.4 ± 61 | 0.08 | 213 ± 53.8 | 240.2 ± 54.6 | 0.08 |
|
|
| 207.2 ± 53.5 | 236.6 ± 54.8 | 0.06 | ||
The comparisons with significant differences are in bold.
Comparisons of the posturographic results between the control group and HIV+.
| Global variables | Open-eyed condition | Closed eye condition | ||||
|---|---|---|---|---|---|---|
| Control | HIV+ |
| Control | HIV+ |
| |
|
| 2.7 ± 1.5 | 2.45 ± 0.9 | 0.81 | 3.2 ± 2.1 | 2.42 ± 1 | 0.32 |
|
| 3.6 ± 1.9 | 3.4 ± 1.5 | 0.67 | 4.35 ± 2.1 | 3.44 ± 1.4 | 0.1 |
|
|
| |||||
|
|
|
| ||||
|
| 268.7 ± 370.1 | 208.9 ± 166.3 | 0.63 | 332.8 ± 358.2 | 200.5 ± 156.9 | 0.23 |
|
| 7.36 ± 5.2 | 5.62 ± 3.9 | 0.2 | 5.3 ± 3.8 | 4.1 ± 2.9 | 0.26 |
|
| 2.62 ± 2.2 | 2.44 ± 1.1 | 0.35 | 3 ± 1.91 | 2.7 ± 1.19 | 0.87 |
|
|
| 2.47 ± 0.57 | 2.74 ± 0.57 | 0.1 | ||
|
| ||||||
|
|
|
|
| |||
|
| 1.01 ± 0.5 | 1.12 ± 0.5 | 0.44 | |||
|
| 0.88 ± 0.4 | 1.05 ± 0.4 | 0.13 | |||
| 0.96 ± 0.4 | 0.98 ± 0.2 | 0.16 | ||||
|
| 0.95 ± 0.3 | 0.98 ± 0.2 | 0.14 | |||
|
| 1.15 ± 1.9 | 1.22 ± 0.7 | 0.09 | |||
CoP disp: displacement of the centre of pressure; MP: mean peak value in the Sway density curve; MD: the mean distance between successive peaks in mm; MT: mean time interval between successive peaks. The comparisons with significant differences are in bold.